{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:13:55Z","timestamp":1774008835477,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background and Aims: Permanent pacemaker (PM) implantation is an established treatment for symptomatic bradycardia. However, chronic right ventricular pacing (RVP) is associated with increased morbidity and mortality due to electrical and mechanical dyssynchrony, leading to pacing-induced cardiomyopathy (PICM). Prognostic markers for identifying patients at high risk of PICM remain scarce. This study compares patients with low (&lt;30%) and high (\u226530%) RVP burden with respect to echocardiographic parameters and clinical outcomes. Methods: This retrospective, double-blinded, single-center study included 105 patients who underwent dual-chamber PM implantation. RVP burden, left ventricular ejection fraction (LVEF), global longitudinal strain (LV-GLS), and all-cause mortality were assessed to evaluate the impact of RVP on LV function and clinical outcomes. Results: At baseline, the mean LVEF was 61 \u00b1 6% and LV-GLS was 18 \u00b1 4%. LVEF declined in seven patients (6.7%) during a mean follow-up of 30 \u00b1 14 months, with a mean reduction from 56.1 \u00b1 4.9% to 40.1 \u00b1 5.0% (median 55% to 41%), thereby fulfilling the prespecified PICM definition (\u226510% decrease from baseline &gt;50%, excluding alternative causes). Of the 105 patients, 58 (55%) were classified into the low RVP group (&lt;30%) and 47 (45%) into the high VP group (\u226530%). High VP burden was associated with deterioration in both LVEF (6\/47 [13%] vs. 1\/58 [2%], p &lt; 0.05) and LV-GLS (28\/47 [60%] vs. 16\/58 [28%], p &lt; 0.001). In multivariable analysis, baseline LV-GLS was significantly associated with subsequent LVEF decline (OR 1.410, 95% CI 1.201\u20131.610, p &lt; 0.001), and high VP burden was linked to LV-GLS decline (OR 1.358, 95% CI 1.160\u20131.534, p &lt; 0.01). Kaplan\u2013Meier analysis showed that time to LVEF deterioration (7 events) was significantly shorter in the high VP burden group (45.2 \u00b1 2.9 vs. 55.7 \u00b1 1.0 months, p &lt; 0.05). Early LV-GLS decline within 1 year predicted subsequent LVEF deterioration (HR 7.210, 95% CI 4.239\u20139.516, p &lt; 0.05), with a significantly shorter time to LVEF deterioration in these patients (34.7 \u00b1 4.2 vs. 53.7 \u00b1 1.4 months, p &lt; 0.001). All-cause mortality did not differ significantly between high and low VP burden groups (p = 0.2). Conclusions: In patients with normal preimplant LVEF and \u226530% RVP, LV-GLS decline of &gt;10% from baseline serves as an early and sensitive marker for subsequent LVEF deterioration and is associated with adverse outcomes. Early LV-GLS monitoring may help identify patients at higher risk for progressive ventricular dysfunction.<\/jats:p>","DOI":"10.3390\/jcm15062361","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:38:01Z","timestamp":1773934681000},"page":"2361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left Ventricular Global Longitudinal Strain Predicts Pacemaker-Associated Cardiomyopathy with Substantial LVEF Deterioration: Results from a Single-Center Cohort Study in Germany"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1907","authenticated-orcid":false,"given":"Carlos","family":"Plappert","sequence":"first","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lacour","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"},{"name":"Kardiologie im Spreebogen and IB Hochschule Berlin, 12683 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul S","family":"Parwani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-0880","authenticated-orcid":false,"given":"Leif-Hendrik","family":"Boldt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"B\u00e4hr","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0123-244X","authenticated-orcid":false,"given":"Doreen","family":"Sch\u00f6ppenthau","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-4329","authenticated-orcid":false,"given":"Henryk","family":"Dreger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Heil","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Hohendanner","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"},{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Mitte, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"},{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Mitte, 10117 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"L\u00fcbcke","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Klinikum Brandenburg, 14770 Brandenburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Hilgendorf","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Blaschke","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center at Charit\u00e9, Campus Virchow Klinikum, 13353 Berlin, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/CIRCULATIONAHA.112.000086","article-title":"New developments in cardiac pacemakers","volume":"127","author":"Vardas","year":"2013","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijcard.2014.03.079","article-title":"Chronic right ventricular apical pacing: Adverse effects and current therapeutic strategies to minimize them","volume":"173","author":"Puchol","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_3","first-page":"71","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)","volume":"24","author":"Glikson","year":"2022","journal-title":"EP Eur."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1093\/eurheartj\/ehz715","article-title":"Pacing-induced cardiomyopathy: Just the tip of the iceberg?","volume":"40","author":"Merchant","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hrthm.2022.09.019","article-title":"Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management","volume":"20","author":"Somma","year":"2023","journal-title":"Heart Rhythm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/eurheartj\/ehz584","article-title":"Incidence of heart failure after pacemaker implantation: A nationwide Danish Registry-based follow-up study","volume":"40","author":"Tayal","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial","volume":"288","author":"Wilkoff","year":"2002","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/eurheartj\/ehr336","article-title":"Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial","volume":"32","author":"Chan","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/CM9.0000000000000856","article-title":"Prognostic factors of pacing-induced cardiomyopathy","volume":"133","author":"Zhang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31083\/j.rcm2504118","article-title":"New Insights into Pacing Induced Cardiomyopathy","volume":"25","author":"Kim","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40001-019-0386-5","article-title":"Pacing-induced cardiomyopathy in chronic right ventricular apical pacing: A midterm follow- up study","volume":"24","author":"Safak","year":"2019","journal-title":"Eur. J. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.amjcard.2010.11.010","article-title":"Defining left bundle branch block in the era of cardiac resynchronization therapy","volume":"107","author":"Strauss","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/eurheartj\/ehs291","article-title":"Right bundle branch block: Prevalence, risk factors, and outcome in the general population: Results from the Copenhagen City Heart Study","volume":"34","author":"Bussink","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","article-title":"2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure","volume":"20","author":"Chung","year":"2023","journal-title":"Heart Rhythm"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/ehf2.14884","article-title":"Redefining anthracycline- related subclinical cardiotoxicity:\u2018Absolute\u2019and \u2018relative\u2019change in longitudinal strain","volume":"11","author":"Terluk","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/2772432816666210901111616","article-title":"Pacemaker induced cardiomyopathy: An overview of current literature","volume":"18","author":"Gavaghan","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa0907555","article-title":"Biventricular pacing in patients with bradycardia and normal ejection fraction","volume":"361","author":"Yu","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ahmed, F.Z., Motwani, M., Cunnington, C., Kwok, C.S., Fullwood, C., Oceandy, D., Fitchet, A., Goode, G.K., Luckie, M., and Zaidi, A.M. (2017). One- month global longitudinal strain identifies patients who will develop pacing-induced left ventricular dysfunction over time: The pacing and ventricular dysfunction (PAVD) study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0162072"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.hrthm.2014.05.040","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy","volume":"11","author":"Khurshid","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ejhf.1427","article-title":"Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy","volume":"21","author":"Cho","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.hlc.2018.11.004","article-title":"Early change in global longitudinal strain is an independent predictor of left ventricular adverse remodelling in patients with right ventricular apical pacing","volume":"28","author":"Xu","year":"2019","journal-title":"Heart Lung Circ."},{"key":"ref_24","first-page":"525","article-title":"Prognostic relevance and lower limit of the reference range of left ventricular global longitudinal strain: A clinical validation study","volume":"18","author":"Morris","year":"2025","journal-title":"Cardiovasc. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/europace\/eur258","article-title":"Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years","volume":"14","author":"Dreger","year":"2012","journal-title":"Europace"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10840-023-01701-x","article-title":"Global longitudinal strain as a risk factor for pacing-induced cardiomyopathy: Another step toward mechanistic insight and prevention strategies","volume":"67","author":"Eaves","year":"2024","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e187419242212020","DOI":"10.2174\/18741924-v16-e221202-2022-8","article-title":"Predictors of impaired left ventricular global longitudinal strain in patients with essential hypertension and preserved ejection fraction","volume":"16","author":"Noori","year":"2022","journal-title":"Open Cardiovasc. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa071880","article-title":"Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease","volume":"357","author":"Sweeney","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/europace\/euv268","article-title":"The risk of atrial fibrillation during right ventricular pacing","volume":"18","author":"Pastore","year":"2016","journal-title":"Europace"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ejhf.157","article-title":"Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trial","volume":"16","author":"Yu","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jacep.2017.10.002","article-title":"Reversal of pacing-induced cardiomyopathy following cardiac resynchronization therapy","volume":"4","author":"Khurshid","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.hrthm.2016.09.027","article-title":"Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function","volume":"13","author":"Kiehl","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jacep.2021.04.003","article-title":"A randomized trial of His pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (His-alternative)","volume":"7","author":"Vinther","year":"2021","journal-title":"Clin. Electrophysiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacep.2022.10.016","article-title":"Clinical outcomes in conduction system pacing compared to right ventricular pacing in bradycardia","volume":"9","author":"Tan","year":"2023","journal-title":"Clin. Electrophysiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1093\/eurheartj\/ehad591","article-title":"Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: A randomized trial","volume":"44","author":"Merkely","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ejhf.2408","article-title":"A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction\u2013insights from the ESC-HFA EORP Heart Failure Long-Term Registry","volume":"24","author":"Benson","year":"2022","journal-title":"Eur. J. Heart Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:09:15Z","timestamp":1774001355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/6\/2361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15062361"],"URL":"https:\/\/doi.org\/10.3390\/jcm15062361","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}